Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    omecamtiv
Show Display Options
Rank Status Study
1 Completed Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)
Condition: Heart Failure
Interventions: Drug: Placebo;   Drug: Omecamtiv mecarbil
2 Withdrawn Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients
Condition: Heart Failure
Intervention: Drug: Omecamtiv mecarbil
3 Completed A Pharmacokinetic and Pharmacodynamic Study of Omecamtiv Mecarbil in Healthy Volunteers
Condition: Heart Failure
Interventions: Drug: placebo;   Drug: omecamtiv mecarbil
4 Recruiting COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
Conditions: Modified Release Oral Formulation;   Left Ventricular Systolic Dysfunction;   Chronic Heart Failure;   History of Chronic Heart Failure;   Left Ventricular Ejection Fraction;   Pharmacokinetics;   Echocardiogram
Interventions: Drug: Omecamtiv mecarbil;   Drug: Placebo;   Drug: Omecamtiv Mecarbil
5 Completed Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency
Condition: Heart Failure
Intervention: Drug: AMG 423
6 Completed
Has Results
Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure
Condition: Heart Failure
Intervention: Drug: CK-1827452

Indicates status has not been verified in more than two years